Clinical Trials: TheraSphere Yttrium-90 Glass: Humanitarian Device Exemption Use Protocol for TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma

Sponsor and Collaborators
University of California, Irvine
MDS Nordion

Contact
Katherine M Gebhardt, PA-C
714-456-3887 
kgebhard@uci.edu

Tricia Hoang, RN
714-456-3886 
triciah@uci.edu

Principal Investigator
David K Imagawa, MD, PhD
University of California, Irvine

ClinicalTrials.gov Identifier
NCT00906984

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs